Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
D000666:Amphotericin B / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy*; D003596:Cytosine / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000382:microbiology; D008099:Liver / Q000382:microbiology; D008297:Male; D051379:Mice; D013154:Spleen / Q000382:microbiology
D000935:Antifungal Agents; D000666:Amphotericin B; D003596:Cytosine; D005437:Flucytosine